<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 9, 1999
MedQuist Inc.
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey 0-19941 22-253 1298
---------- ------- -----------
(State or other (Commission (I.R.S. Employer
jurisdiction File Identification No.)
of incorporation Number)
or organization)
Five Greentree Centre
Suite 311
Marlton, NJ 08053
--------------------------------------------------
(address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (609) 596-8877
<PAGE>
Item 5 - Other Events
- ---------------------
On April 9, 1999, MedQuist Inc. entered into an agreement with Lanier
Worldwide, Inc. for MedQuist to acquire substantially all of the assets of
Lanier Transcription Services, a national provider of medical transcription
services located in Atlanta, Georgia. If completed, this acquisition will
further expand our client base, network of transcriptionists and geographic
presence. During fiscal year 1998, Lanier Transcription Services generated
revenue of approximately $25 million, operating through a network consisting of
30 offices and 550 transcriptionists. MedQuist intends to integrate Lanier
Transcription Services into MedQuist's existing operations. The purchase price
is $35 million and the transaction will be accounted for as a purchase of assets
and is scheduled to close during the second quarter of 1999. The completion of
the acquisition is subject to regulatory approval and other customary conditions
to closing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDQUIST INC.
Date: April 16, 1999 By:
---------------------------------
Name: John M. Suender
Title: Senior Vice President and
General Counsel
2
